How early can OncoK9 detect cancer?
OncoK9 has been designed to detect cancer-associated genomic alterations that are present even in very early-stage cancers. As a result, OncoK9 may detect cancer early, while it is still localized to the primary site and can be treated with curative intent. A positive test result indicates the presence of malignant tumor in the body. The fraction of cancer cases detectable by the test increases with cancer stage. When used for screening in patients without clinical signs suggestive of cancer, repeat testing at annual intervals will increase the likelihood of detecting cancer by OncoK9.